FDA applicant
Medtronic Neuromodulation
FDA records 5 decisions for Medtronic Neuromodulation (Minneapolis) from 1984 to 2025: 1 De Novo grant and 4 original PMA approvals. Most are in product codes EZW (Stimulator, Electrical, Implantable, For…) and QPT (Stimulator, Tibial, Electrical, Implantable…). 14 recalls are linked to its devices.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Medtronic Neuromodulation’s devices, and how often a recall has named them.
FDA decisions per year
1in 2025
2026 so far, outlined.
Recalls per year
1in 2025
Class I Class II/III not classified
Planning a device like Medtronic Neuromodulation’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) Report